mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
PF-750 |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.5 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.5 |
mRNA |
SJ-172550 |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.5 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.5 |
mRNA |
WZ8040 |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.5 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.5 |
mRNA |
BRD-K16147474 |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.5 |
mRNA |
BRD-K16130065 |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.5 |
mRNA |
BRD-K34099515 |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.5 |